The phase III candidate: Can we improve the science of selection? Journal Article
| Author: | Bajorin, D. |
| Article Title: | The phase III candidate: Can we improve the science of selection? |
| Keywords: | cancer survival; treatment outcome; clinical trial; cisplatin; doxorubicin; drug efficacy; patient selection; gemcitabine; research design; methotrexate; methodology; antineoplastic agent; evidence based medicine; neoplasm; evidence-based medicine; neoplasms; mucosa inflammation; antineoplastic combined chemotherapy protocols; editorial; oncology; bladder cancer; cancer research; vinblastine; febrile neutropenia; patient care; cystectomy; clinical research; medical oncology; phase 3 clinical trial; research subject; toxicity; decision making; granulocyte colony stimulating factor; patient care planning; giant cell tumor; clinical trials, phase iii; humans; prognosis; human; priority journal |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 22 |
| Issue: | 2 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2004-01-15 |
| Start Page: | 211 |
| End Page: | 213 |
| Language: | English |
| DOI: | 10.1200/jco.2004.10.988 |
| PUBMED: | 14665614 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Cited By (since 1996):18 -- Export Date: 16 June 2014 -- CODEN: JCOND -- Source: Scopus |
